Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain

NCT04967664 is registered in ClinicalTrials.gov with Averitas Pharma, Inc. as lead sponsor.

NCT NCT04967664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04967664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Phase III, Double-blind, Randomized, Controlled, Parallel-group, Multi-site, Clinical Trial Evaluating the Efficacy and Safety of Qutenza® in Subjects With Post-surgical Neuropathic Pain
Lead sponsor
Averitas Pharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 13, 2021
Completion date
August 28, 2025
Enrollment
412 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

post surgical neuropathic pain